Reducing Visceral Fat Protects the Brain for Decades

Summary: A new longitudinal study reveals that the accumulation of visceral fat, the “hidden” fat stored deep within the abdominal cavity, is a primary driver of brain atrophy and cognitive decline in late midlife.

By following 533 participants for up to 16 years using repeated MRI scans, researchers found that sustained lower levels of visceral fat are associated with the preservation of brain volume and superior cognitive performance, independent of overall weight loss. The study identifies glucose control and insulin sensitivity as the biological bridge connecting abdominal health to brain longevity.

Key Research Findings

  • Brain Structure Preservation: Lower cumulative visceral fat over the years was linked to higher total brain volume, greater gray matter volume, and a higher Hippocampal Occupancy Score—a critical marker for memory and aging.
  • Atrophy Markers: Elevated visceral fat levels were associated with a faster expansion of the brain ventricles, a well-established sign of brain atrophy.
  • The Glucose Link: The relationship between abdominal fat and brain aging appears to be mediated primarily through glycemic balance. Fasting glucose and HbA1c levels were the only markers that consistently predicted structural brain changes over time.
  • Specificity of Fat: These neuroprotective associations were exclusive to visceral fat. No similar relationship was found for subcutaneous fat (fat stored just under the skin) or Body Mass Index (BMI), suggesting that weight alone is an insensitive marker for brain health.
  • Early Intervention Payoff: Reductions in visceral fat during an initial 18-month dietary intervention predicted better brain structure preservation 5 to 10 years later, regardless of whether weight was regained.

Source: Ben-Gurion University of the Negev

A groundbreaking long-term MRI study demonstrates that lower accumulation of abdominal fat (visceral fat), measured throughout the entire follow-up period, is associated with a significant slowing of brain atrophy, preservation of key brain structures, and better cognitive performance in late midlife – independent of weight loss.

The findings suggest that the relationship between abdominal fat and brain aging is likely mediated primarily through glucose control and insulin sensitivity. The study is the first to link repeated MRI-based measurements of cumulative visceral fat with long-term trajectories of brain aging and cognition.

This shows the outline of two people and brains.
Sustained accumulation of visceral fat is linked to accelerated brain atrophy and cognitive decline, a process primarily mediated by glucose metabolism and insulin resistance. Credit: Neuroscience News

The study’s findings were published in Nature Communications.

The study is based on advanced MRI imaging of the brain and abdomen and includes 533 women and men in late midlife who were followed for 5 to 16 years after participating in four large, long-term, controlled dietary clinical trials: DIRECT, CASCADE, CENTRAL, and DIRECT-PLUS, led by Prof. Iris Shai of Ben-Gurion University of the Negev, Dean of the School of Sustainability at Reichman University, and an adjunct Professor at Harvard University. During follow-up, repeated MRI measurements of visceral fat and brain structures were conducted, along with cognitive assessment using the MoCA test.

The findings show that lower accumulation of visceral fat over the years was associated with higher MoCA scores, as well as preservation of total brain volume, gray matter volume, and the Hippocampal Occupancy Score – a sensitive marker of brain aging and memory. In parallel, a slowing in the expansion of the brain ventricles was observed, a process that constitutes a well-established marker of brain atrophy.

Prof. Iris Shai: “The findings point to glucose control and reduction of visceral abdominal fat as measurable, modifiable, and achievable targets in midlife – with real potential to slow brain degeneration and reduce the risk of cognitive decline.”

The study was conducted at Ben-Gurion University of the Negev in collaboration with researchers from Harvard University, Leipzig University, and Tulane University.

A unique longitudinal follow-up, which included three brain MRI scans over five years in a subgroup of participants, showed that persistently elevated levels of visceral fat over time were associated with a faster rate of brain volume loss, particularly in the hippocampus, and with accelerated enlargement of the brain ventricles. These associations were not observed for subcutaneous fat, either superficial or deep, nor for body mass index (BMI), highlighting the biological specificity of visceral fat.

Moreover, the study found that reductions in visceral fat during an 18-month dietary intervention predicted better preservation of brain structures 5 and 10 years later, even after adjustment for weight loss and other factors. In other words, the reduction in abdominal fat itself – rather than weight loss per se – was the factor predicting long-term brain outcomes.

The study indicates that the association between visceral fat and brain aging is mediated primarily through glycemic balance. Fasting glucose and HbA1c levels were the only markers that predicted the rate of structural brain change over time, whereas blood lipid markers or inflammatory markers did not show a similar association.

These findings support the hypothesis that insulin resistance and chronic dysregulation of glucose metabolism impair cerebral perfusion, compromise blood–brain barrier integrity and accelerate degeneration of gray matter and the hippocampus.

Dr. Dafna Pachter, the study’s first author, said: “Weight alone is not a sensitive marker of the profound metabolic changes occurring in the body. We found that even when weight loss is modest, sustained reductions in visceral fat – as measured across the entire period – are associated with preservation of brain structure and a slower rate of atrophy.”

Breakthrough Brain Study

This is the largest and longest study to date linking cumulative exposure to visceral fat and brain measures, assessed longitudinally using MRI, with the rate of brain aging and cognitive function. The integration of repeated measurements of abdominal fat, brain structures, and cognition makes it possible, for the first time, to identify a specific metabolic target – rather than general obesity – as a modifiable brain risk factor.

Funding: This study was funded by grants from the German Research Foundation (DFG; LeiCeM, center of Excellence) and the ERA-4-Health initiative.

Key Questions Answered:

Q: If I lose weight but keep my “belly fat,” is my brain still at risk?

A: According to this study, yes. The researchers found that visceral fat specifically—not BMI or subcutaneous fat—is the factor that predicts brain atrophy. This means even “skinny” individuals with high internal abdominal fat may face accelerated brain aging.

Q: How does belly fat actually damage the brain?

A: It likely comes down to insulin resistance and glucose dysregulation. Chronic mismanagement of blood sugar can impair blood flow to the brain, compromise the blood-brain barrier, and trigger the degeneration of gray matter and the hippocampus.

Q: Is it ever too late to start a diet to save my brain?

A: The study suggests that midlife is a critical “modifiable” window. Interestingly, even an 18-month push to reduce visceral fat showed neuroprotective benefits a decade later, suggesting that early, sustained efforts to control abdominal fat pay long-term dividends for cognitive health.

Editorial Notes:

  • This article was edited by a Neuroscience News editor.
  • Journal paper reviewed in full.
  • Additional context added by our staff.

About this cognition and aging research news

Author: Ehud Zion Waldoks
Source: Ben-Gurion University of the Negev
Contact: Ehud Zion Waldoks – Ben-Gurion University of the Negev
Image: The image is credited to Neuroscience News

Original Research: Open access.
Sustained visceral fat loss is associated with attenuated brain atrophy and improved cognitive function in late midlifex” by Dafna Pachter, Hadar Klein, Omer Kamer, Dana Tamar Goldberg Toren, Liav Alufer, Noa Ebstein Karamani, Tomer Atlas, Amit Yaary, Idan Hagbi, Yoash Chassidim, Ilan Shelef, Moti Salti, Frauke Beyer, Veronica Witte, Assaf Rudich, Uri Yoel, Gal Ben-Arie, Anat Yaskolka Meir, Alon Kaplan, Gal Tsaban, Hila Zelicha, Carmi Bartal, Lu Qi, Matthias Blüher, Michael Stumvoll, Uta Ceglarek, Berend Isermann, Dong D. Wang, Meir J. Stampfer, Frank B. Hu, Galia Avidan & Iris Shai. Nature Communications
DOI:10.1038/s41467-026-71141-4


Abstract

Sustained visceral fat loss is associated with attenuated brain atrophy and improved cognitive function in late midlife

We examined whether long-term exposure to visceral-adipose-tissue (VAT) influences brain atrophy and cognitive performance years after lifestyle intervention.

In the Follow-Interventions-Trials (FIT) project, 533 adults (age=61.4 y, 86% men) from four prior 18-24-month lifestyle randomized-clinical-trials underwent abdominal/brain magnetic-resonance-imaging (MRI)s and Montreal-Cognitive-Assessment (MoCA) testing 5–16 y after interventions.

Lower VAT exposure, calculated by area-under-the-curve, from baseline, post-intervention, and follow-up, independently resulted in higher MoCA scores. VAT loss during intervention predicted higher brain volumes at follow-up, independent of weight loss. Among participants with three brain and VAT MRI scans, lower long-term VAT was associated with a slower rate of brain atrophy.

These patterns were not observed for deep/superficial subcutaneous-adipose-tissues. Improved glycemic control parameters, rather than lipid or inflammatory markers, were mostly related to the favorable longitudinal brain outcomes.

This long-term, large-scale intervention and follow-up MRI study suggests that sustained visceral fat loss, rather than weight loss, is linked to better cognition and attenuation of brain atrophy years later, mainly via improved glycemic control. 

Trial registration: DIRECT (Clinical-trials-identifier: NCT00160108); CASCADE (Clinical-trials-identifier: NCT00784433); CENTRAL (Clinical-trials-identifier: NCT01530724); DIRECT-PLUS (Clinical-trials-identifier: NCT03020186).

Join our Newsletter
I agree to have my personal information transferred to AWeber for Neuroscience Newsletter ( more information )
Sign up to receive our recent neuroscience headlines and summaries sent to your email once a day, totally free.
We hate spam and only use your email to contact you about newsletters. You can cancel your subscription any time.